Self-Assembling Peptide Gel Could Replace the Vitreous Humor in Eye Surgery | Research

The takeaway

A negatively charged self-assembling peptide hydrogel (3E-OX) closely matched the optical and physical properties of natural vitreous humor and showed safety and biocompatibility in animal studies.

Matched native vitreous properties
The 3E-OX peptide hydrogel closely replicated the optical clarity, refractive index, molecular permeability, and viscoelasticity of natural vitreous humor — key requirements for a functional vitreous substitute.

What the researchers found

The negatively charged peptide hydrogel 3E-OX demonstrated physicochemical properties closely resembling native vitreous humor, including optimal light transmittance, refractive index, molecular permeability, and viscoelasticity. In contrast, the positively charged variant (3K-OX) was less suitable.

Animal studies in rabbits confirmed the safety and biocompatibility of 3E-OX as a vitreous substitute. The researchers also introduced optical coherence tomography (OCT) for retinal microvascular detection in non-pigmented rabbits as a novel method to evaluate intraocular tamponade materials, providing more detailed assessment of retinal health after vitreous replacement.

Why it matters

Current vitreous substitutes (silicone oil, gas, saline) all have significant limitations — silicone oil requires a second surgery for removal and can cause complications, while gas and saline are temporary. A biocompatible, injectable peptide hydrogel that mimics natural vitreous properties could eliminate the need for removal surgery and provide a permanent, well-tolerated substitute for patients undergoing vitreoretinal surgery.

How the study worked

Researchers designed and synthesized two self-assembling peptide hydrogels with opposite charges (3K-OX positive, 3E-OX negative). In vitro characterization included light transmittance, refractive index, molecular permeability, viscoelasticity, and biocompatibility testing. In vivo studies were conducted in rabbits, using the hydrogels as vitreous substitutes after vitrectomy. Optical coherence tomography was used to evaluate retinal health and microvascular integrity in non-pigmented rabbits.

What this study cannot tell us

The study was conducted in rabbits, and the long-term biocompatibility and performance in human eyes remain to be established. The observation period for animal studies was not specified in the abstract. No comparison with current clinical vitreous substitutes was described. Manufacturing scalability and regulatory pathway for a peptide hydrogel medical device were not addressed. Human clinical trials are needed before clinical adoption.

How to read the evidence

This is a preclinical study with in vitro characterization and rabbit model validation. The results are promising but represent an early stage of development. No human data or comparison with approved vitreous substitutes is available.

When this study was published

Published in 2024, this study represents current advances in peptide-based biomaterials for ophthalmology.

The bigger picture

Self-assembling peptide hydrogels represent a growing frontier in biomaterials. Their ability to form gel-like structures from simple peptide building blocks makes them attractive for medical applications where biocompatibility and precisely tunable properties are essential. This work extends peptide hydrogel applications from tissue engineering and drug delivery into ophthalmology, demonstrating the versatility of peptide-based materials in medicine.

Questions still open

How does 3E-OX perform compared to silicone oil and other vitreous substitutes in long-term animal studies?
Will the peptide hydrogel maintain its properties over months to years inside the human eye?
Could this hydrogel also serve as a drug delivery platform for sustained release of medications inside the eye?

Common questions

Why do eyes need a vitreous substitute after surgery?

The vitreous humor is the clear gel that fills the inside of the eye and helps maintain its shape. During surgery for conditions like retinal detachment, the vitreous may need to be removed. Current replacements like silicone oil work temporarily but have drawbacks including the need for a second surgery to remove them. A biocompatible gel that stays in place permanently would be ideal.

What makes this peptide hydrogel better than current vitreous substitutes?

Unlike silicone oil (which can cause complications and requires removal) or gas bubbles (which are temporary), this self-assembling peptide hydrogel is designed to closely match the natural vitreous in clarity, flexibility, and molecular properties. It is biocompatible and injectable, and in animal studies it appeared safe and well-tolerated, potentially offering a permanent solution.

Read the original research

Injectable self-assembling peptide hydrogel as a promising vitreous substitute.

Journal of controlled release : official journal of the Controlled Release Society, 376, 402-412

View on PubMed ↗Publisher’s paper ↗

Citation

Cai, Yuting; Xiang, Yatong; Dong, Huilei; Huang, Wenjing; Liu, Yan; Zhao, Chenguang; Yuan, Dan; Li, Yun; Shi, Junfeng. (2024). Injectable self-assembling peptide hydrogel as a promising vitreous substitute.. Journal of controlled release : official journal of the Controlled Release Society, 376, 402-412. https://doi.org/10.1016/j.jconrel.2024.10.016